The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Abstract
Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prime example is provided by cardiac failure, where the level of elevation of the plasma concentration of norepinephrine in plasma predicts reduced longevity.18”
From Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) · cites this paper as [18]
In the citing paper
“Ongoing systemic sympathetic activation has long been thought to be noxious, in heart failure 18,19 and renal failure.113”
From Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? (2018) · cites this paper as [18]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citationUse of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439
Research works printed but not linked: 2
- Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
Items 701–800 of 1,002
Somato‐dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation
Brown, C. H., Ludwig, M., Tasker, J. G., & Stern, J. E. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12856 · Cited by 72
Cardioprotection: definition, classification, and fundamental principles.
Kübler, W., & Haass, M. (1996) · Heart · doi:10.1136/hrt.75.4.330 · Cited by 68
Metabolic and nutritional disorders in cardiac cachexia
Mustafa, I., & Leverve, X. M. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00627-x · Cited by 67
Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure
Cipolla, C. M., Grazi, S., Rimondini, A., Susini, G., Guazzi, M., Bella, P. E. D., & Guazzi, M. D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90938-w · Cited by 67
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Fujii, M., Matsumoto, T., Yamamoto, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01576-5 · Cited by 67
Cody, R. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050029006 · Cited by 67
Plasma norepinephrine in Chagas' cardioneuromyopathy: A marker of progressive dysautonomia
Iosa, D. J., DeQuattro, V. L., Lee, D. D.-P., Elkayam, U., & Palmero, H. A. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90627-3 · Cited by 67
Current role of beta-adrenergic blockers in the management of chronic heart failure
Packer, M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00676-3 · Cited by 66
Murphy, D. J., Knaus, W. A., & Lynn, J. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90213-9 · Cited by 67
Acupuncture in the Treatment of Heart Failure
Middlekauff, H. R. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000103650.71735.f0 · Cited by 66
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure
Nakamura, T., Funayama, H., Yoshimura, A., Tsuruya, Y., Saito, M., Kawakami, M., & Ishikawa, S. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.043 · Cited by 66
Wang, H., Rozanski, G. J., & Zucker, I. H. (2017) · The Journal of Physiology · doi:10.1113/jp273764 · Cited by 66
Chen, W., Ling, Z., Xu, Y., Liu, Z., Su, L., Du, H., Xiao, P., Lan, X., Shan, Q., & Yin, Y. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26475 · Cited by 66
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis
Aimo, A., Vergaro, G., Castiglione, V., Rapezzi, C., & Emdin, M. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.015 · Cited by 66
Functional Effects of Endogenous Bradykinin in Congestive Heart Failure
Cheng, C., Onishi, K., Ohte, N., Suzuki, M., & Little, W. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00159-4 · Cited by 66
Basic mechanisms of disease progression in the failing heart: The role of excessive adrenergic drive
Mann, D. L. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80025-x · Cited by 66
Maisel, A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1774 · Cited by 65
Packer, M., Lee, W. H., Medina, N., Yushak, M., Bernstein, J. L., & Kessler, P. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80135-3 · Cited by 66
Differential Effects of Captopril and Nitrates on Muscle Sympathetic Nerve Activity in Volunteers
Noll, G., Wenzel, R. R., de Marchi, S. F., Shaw, S., & Lüscher, T. F. (1997) · Circulation · doi:10.1161/01.cir.95.9.2286 · Cited by 65
Sequential neurohumoral measurements in patients with congestive heart failure
Francis, G. S., Rector, T. S., & Cohn, J. N. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90729-6 · Cited by 66
Self-citationKetchum, E. S., Jacobson, A. F., Caldwell, J. H., Senior, R., Cerqueira, M. D., Thomas, G. S., Agostini, D., Narula, J., & Levy, W. C. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9603-0 · Cited by 63
The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology
Kaumann, A. J., & Molenaar, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.03.009 · Cited by 65
Prognostic Value of Plasma Renin Activity in Heart Failure
Vergaro, G., Emdin, M., Iervasi, A., Zyw, L., Gabutti, A., Poletti, R., Mammini, C., Giannoni, A., Fontana, M., & Passino, C. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.034 · Cited by 65
Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis
Schrier, R. W., Gurevich, A. K., & Cadnapaphornchai, M. A. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.20933 · Cited by 65
Insulin Signalling and Resistance in Patients with Chronic Heart Failure
Kemppainen, J., Tsuchida, H., Stolen, K. Q., Karlsson, H., Björnholm, M., Heinonen, O. J., Nuutila, P., Krook, A., Knuuti, J. M., & Zierath, J. R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042648 · Cited by 65
McKelvie, R. S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00477-9 · Cited by 65
Weig, H., Laugwitz, K., Moretti, A., Kronsbein, K., Städele, C., Brüning, S., Seyfarth, M., Brill, T., Schömig, A., & Ungerer, M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1578 · Cited by 65
Novel Interventional Therapies to Modulate the Autonomic Tone in Heart Failure
Chatterjee, N. A., & Singh, J. P. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.05.008 · Cited by 62
Teerlink, J. R., Gray, G. A., Clozel, M., & Clozel, J. (1994) · Circulation · doi:10.1161/01.cir.89.1.393 · Cited by 64
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
Capone, F., Vacca, A., Bidault, G., Sarver, D. C., Kamińska, D., Strocchi, S., Vidal‐Puig, A., Greco, C. M., Lusis, A. J., & Schiattarella, G. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325492 · Cited by 76
Lindenfeld, J., Ghali, J. K., Krause-Steinrauf, H. J., Khan, S. S., Adams, K. F., Goldman, S., Peberdy, M. A., Yancy, C. W., Thaneemit-Chen, S., Larsen, R. L., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00938-0 · Cited by 63
Gilbert, E. M., Lenarda, A. D., & O’Connell, J. B. (1993) · Springer eBooks · doi:10.1007/978-3-642-77598-7_5 · Cited by 64
Independent control of skin and muscle sympathetic nerve activity in patients with heart failure.
Middlekauff, H. R., Hamilton, M. A., Stevenson, L. W., & Mark, A. L. (1994) · Circulation · doi:10.1161/01.cir.90.4.1794 · Cited by 62
Wenzel, R. R., Spieker, L. E., Qui, S., Shaw, S., Lüscher, T. F., & Noll, G. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.1022 · Cited by 64
Mende, U., Thomas Eschenhagen, A., Geertz, B., Schmitz, W. L., Scholz, H., Esch, J. S. A., Sempell, R., & Steinfath, M. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00175468 · Cited by 63
Brouwer, J., van Veldhuisen, D. J., Veld, A. J. M. I. '., Dunselman, P. H. J. M., Boomsma, F., Haaksma, J., & Lie, K. I. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00285-3 · Cited by 63
Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates
Kahn, J. P., DRUSIN, R. E., & Klein, D. F. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.10.1327 · Cited by 63
Follick, M. J., Gorkin, L., Capone, R. J., Smith, T. W., Ahern, D. K., Stablein, D. M., NIAURA, R. S., & Visco, J. P. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90246-3 · Cited by 63
Isoprenaline-induced increase in mRNA levels of inhibitory G-protein ?-subunits in rat heart
Thomas Eschenhagen, A., Mende, U., Nose, M., Schmitz, W. L., Scholz, H., Warnholtz, A., & Wiistel, J.-M. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00184292 · Cited by 63
Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes
Pour, P. A., Hosseinian, S., & Kheradvar, A. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00152.2021 · Cited by 65
Cardiac biomarkers: new tools for heart failure management.
Iqbal, N., Wentworth, B., Choudhary, R., Landa, A. D. L. P., Kipper, B., Fard, A., & Maisel, A. (2012) · Cardiovascular Diagnosis and Therapy · doi:10.3978/j.issn.2223-3652.2012.06.03 · Cited by 59
Omland, T., Dickstein, K., & Syversen, U. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01425-0 · Cited by 62
Xiao, L., Gao, L., Lazartigues, E. D., & Zucker, I. H. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.176636 · Cited by 62
Renal Denervation and Heart Failure
Böhm, M., Ewen, S., Kindermann, I., Linz, D., Ukena, C., & Mahfoud, F. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.83 · Cited by 62
Leptin as a new diagnostic tool in chronic heart failure
Schulze, P. C., & Kratzsch, J. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.05.019 · Cited by 62
Why study sympathetic nervous system?
Siński, M., Lewandowski, J., Abramczyk, P., Narkiewicz, K., & Gaciong, Z. A. (2006) · PubMed · Cited by 60
Wang, Z., Taylor, L. K., Denney, W. D., & Hansen, D. E. (1994) · Circulation · doi:10.1161/01.cir.90.4.2022 · Cited by 62
B�hm, M., Ros�e, K., Schmidt, U. H., Schulz, C., Schwinger, R. H. G., & Erdmann, E. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00235525 · Cited by 62
Beckers, F., Ramaekers, D., & AUBERT, A. E. (2001) · Cardiovascular Engineering An International Journal · doi:10.1023/a:1015212328405 · Cited by 62
Simmons, W. W., Freeman, M. R., Grima, E. A., Hsia, T., & Armstrong, P. W. (1994) · Circulation · doi:10.1161/01.cir.89.6.2843 · Cited by 62
Value of carvedilol in congestive heart failure secondary to coronary artery disease
Gupta, P. D., Broadhurst, P., Raftery, E. B., & Lahiri, A. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90515-3 · Cited by 62
The short-term effect of water-pipe smoking on the baroreflex control of heart rate in normotensives
Al-Kubati, M., Al-Kubati, A. S., Al’Absi, M., & Fišer, B. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.03.007 · Cited by 61
Cardiac sympathetic activation in patients with pulmonary arterial hypertension
Mak, S. S., Witte, K. K., Al‐Hesayen, A., Granton, J. T., & Parker, J. D. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00652.2011 · Cited by 61
Gerson, M. C., Caldwell, J. H., Ananthasubramaniam, K., Clements, I. P., Henzlova, M. J., Amanullah, A. M., & Jacobson, A. F. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.954784 · Cited by 61
Horiuchi, Y., Aoki, J., Tanabe, K., Nakao, K., Ozaki, Y., Kimura, K., Ako, J., Yasuda, S., Noguchi, T., Suwa, S., et al. (2018) · International Heart Journal · doi:10.1536/ihj.17-009 · Cited by 61
Regulation of β-Adrenoceptor Signaling in Cardiac Function and Disease
Dzimiri, N. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01415-7 · Cited by 140
Nozaki, N., Yamaguchi, S., Shirakabe, M., Nakamura, H., & Tomoike, H. (1997) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.61.657 · Cited by 61
Imamura, Y., Fukuyama, T., Mochizuki, T., Miyagawa, M., Watanabe, K., & F, O. B. O. T. E. M. H. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.155 · Cited by 61
Dubois‐Randé, J., Merlet, P., Roudot‐Thoraval, F., Benvenuti, C., Adnot, S., Hittinger, L., Duval, A., Syrota, A., Castaigne, A., Loisance, D. Y., et al. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90278-4 · Cited by 61
Nagaoka, H., Isobe, N., Kubota, S., lizuka, T., Imai, S., Suzuki, T., & Nagai, R. (1997) · CHEST Journal · doi:10.1378/chest.111.2.344 · Cited by 61
Sanderson, J. E., Chan, W., Hung, Y. T., Chan, S. K. C., Shum, I. O. L., Raymond, K., & Woo, K. S. (1995) · Heart · doi:10.1136/hrt.74.5.502 · Cited by 61
Levine, T. B., Olivari, M. T., & Cohn, J. N. (1986) · The American Journal of Cardiology · doi:10.1016/s0002-9149(86)80034-0 · Cited by 60
Self-citationEsler, M., Lambert, G., Schlaich, M., Dixon, J., Sari, C. I., & Lambert, E. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09790 · Cited by 60
Depression and heart failure: An overview of what we know and don’t know
Silver, M. A. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77.s3.02 · Cited by 60
Nagatsu, M., Zile, M. R., Tsutsui, H., Schmid, P. G., DeFreyte, G., Cooper, G., & Carabello, B. A. (1994) · Circulation · doi:10.1161/01.cir.89.2.818 · Cited by 60
Asakura, M., Asanuma, H., Kim, J., Liao, Y., Nakamaru, K., Fujita, M., Komamura, K., Isomura, T., Furukawa, H., Tomoike, H., et al. (2007) · Hypertension Research · doi:10.1291/hypres.30.781 · Cited by 62
Stratton, J. R., & Halter, J. B. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90582-x · Cited by 60
Kiilavuori, K. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1277 · Cited by 60
Li, D., Wang, L., Lee, C.-W., Dawson, T., & Paterson, D. J. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088591 · Cited by 60
LINDE‐EDELSTAM, C., Gullberg, B., Norlander, R., PEHRSSON, S. K., Rosenqvist, M., & Rydén, L. (1992) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1992.tb06500.x · Cited by 60
Influence of Arterial Baroreceptors on Heart Rate Variability
Piepoli, M. F., & Bernardi, L. (1998) · Medical Principles and Practice · doi:10.1159/000026028 · Cited by 60
Waldschmidt, H. V., Homan, K. T., Cruz-Rodríguez, O., Cato, M. C., Waninger‐Saroni, J., Larimore, K. M., Cannavò, A., Song, J., Cheung, J. Y., Kirchhoff, P. D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02000 · Cited by 59
Salatzki, J., Foryst‐Ludwig, A., Bentele, K., Blumrich, A., Smeir, E., Bán, Z., Brix, S., Grune, J., Beyhoff, N., Klopfleisch, R., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007171 · Cited by 59
Schalcher, C., Cotter, G., Reisin, L., Bertel, O., Kobrin, I., Guyene, T.-T., & Kiowski, W. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116760 · Cited by 59
Omland, T., Aarsland, T., Aakvaag, A., Lie, R. T., & Dickstein, K. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90669-4 · Cited by 59
Takeyama, J., Itoh, H., Katô, M., Koike, A., Aoki, K., Fu, L.-T., Watanabe, H., Nagayama, M., & Katagiri, T. (2000) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.64.809 · Cited by 57
Plasma norepinephrine and mortality
Cohn, J. N. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181304 · Cited by 58
Self-citationSpyrou, N., Rosen, S. D., Fath‐Ordoubadi, F., Jagathesan, R., Foale, R. A., Kooner, J. S., & Camici, P. G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02162-9 · Cited by 58
Takahashi, T., Anzai, T., Yoshikawa, T., Maekawa, Y., Asakura, Y., Satoh, T., Mitamura, H., & Ogawa, S. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00416-3 · Cited by 58
Kaye, D. M., Jennings, G., Dart, A. M., & Esler, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00525-1 · Cited by 58
Alpert, N. R., Leavitt, B. J., Ittleman, F. P., Hasenfuss, G. P., Pieske, B. M., & Mulieri, L. A. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050200 · Cited by 58
Paolisso, G., Gambardella, A., Marrazzo, G., Verza, M., Teasuro, P., Varricchio, M., & D’Onofrio, F. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90753-i · Cited by 58
Panina, G., Khot, U. N., Nunziata, E., Cody, R. J., & Binkley, P. F. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90325-9 · Cited by 58
Packer, M., Gottlieb, S. S., & Kessler, P. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90337-2 · Cited by 58
Prognostic Value of Chromogranin A in Chronic Heart Failure: Data from the GISSI-Heart Failure Trial
Røsjø, H. R., Masson, S., Latini, R., Flyvbjerg, A., Milani, V., Rovere, M. T. L., Revera, M., Mezzani, A., Tognoni, G., Tavazzi, L., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq055 · Cited by 57
Sympathetic nervous system activation, arterial shear rate, and flow-mediated dilation
Thijssen, D. H. J., Atkinson, C. L., Ono, K., Sprung, V. S., Spence, A. L., Pugh, C. J. A., & GREEN, D. J. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00110.2014 · Cited by 57
Dalal, S., Foster, C. R., Das, B. C., Singh, M., & Singh, K. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1205-7 · Cited by 57
Smilde, T. D. J., van Veldhuisen, D. J., & van den Berg, M. P. (2009) · Clinical Research in Cardiology · doi:10.1007/s00392-009-0747-0 · Cited by 57
Neurohumoral activation in heart failure: the role of adrenergic receptors
Brum, P. C., Rolim, N. P. L., Bacurau, A. V. N., & Medeiros, A. (2006) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652006000300009 · Cited by 60
Waldschmidt, H. V., Homan, K. T., Cato, M. C., Cruz-Rodríguez, O., Cannavò, A., Wilson, M. W., Song, J., Cheung, J. Y., Koch, W. J., Tesmer, J. J. G., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00112 · Cited by 57
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., Dell’Oro, R., Facchetti, R., & Mancia, G. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14804 · Cited by 57
Circadian rhythm and sudden death in heart failure
Carson, P. E., O’Connor, C. M., Miller, A. B., Anderson, S., Belkin, R. N., Neuberg, G. W., WERTHEIMER, J. H., Frid, D. J., Cropp, A., & Packer, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00728-2 · Cited by 57
Ryanodine Receptor‐Targeted Anti‐Arrhythmic Therapy
Wehrens, X. H. T., Lehnart, S. E., & Marks, A. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1341.032 · Cited by 57
Grassi, G. M., Seravalle, G., Bertinieri, G., Turri, C., Stella, M. L., Scopelliti, F., & Mancia, G. (2001) · Clinical Science · doi:10.1042/cs1010141 · Cited by 57
Kubo, T., Azevedo, E. R., Newton, G. E., Parker, J. D., & Floras, J. S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01577-7 · Cited by 57
β-Adrenergic signal transduction in the failing and hypertrophied myocardium
Böhm, M., Flesch, M., & Schnabel, P. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050175 · Cited by 58
Sympathetic transduction in humans: recent advances and methodological considerations
Young, B. E., Greaney, J. L., Keller, D. M., & Fadel, P. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2020 · Cited by 57
Central and peripheral sympathetic activation in heart failure
Grassi, G. M., Mancia, G., & Esler, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab222 · Cited by 56
de Berrazueta, J. R., Guerra-Ruiz, A. R., García‐Unzueta, M. T., Toca, G. M., Laso, R. S., Herrero, M. S. D. A., Martín, M. A. C., Cobo, M., & Llorca, J. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq036 · Cited by 56
Establishing Prognosis in Heart Failure: A Multimarker Approach
Ketchum, E. S., & Levy, W. C. (2011) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2011.03.003 · Cited by 56
Metadata
- Authors
- Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
- Affiliations
- University of Minnesota (US)
- ORCID
- Cohn, Jay N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-09-27
- Volume
- 311
- Issue
- 13
- Pages
- 819-823
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338638760
- Cited by
- 3,125
- References
- 23
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
- FWCI
- 34.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
- MeSH terms
- Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review